Special Issue "Natural Products and Their Modifications as Agents Used in the Fight against Pathogens"
Deadline for manuscript submissions: 29 February 2024 | Viewed by 190
Interests: flavonoid; natural compounds; biological activity; anticancer activity; antioxidant activity; chalcone; multidrug-resistant pathogens; food science; antimicrobial agents; cytotoxicity assays; amyloid; Crohn's disease; AIEC; biofilm
Special Issues, Collections and Topics in MDPI journals
Special Issue in Antibiotics: Antimicrobial Activity of Different Plant Extracts, Plant-Derived Compounds and Synthetic Derivatives of Natural Compounds on Pathogenic Microorganisms, 2nd Volume
The problem of the resistance of bacterial strains to commercially available antibiotics keeps clinicians around the world awake at night. Therefore, the search for new compounds of natural origin is crucial in solving this problem. It is crucial that these products simultaneously protect the intestinal microbiota, which plays a huge role in maintaining the health of the entire body.
Various extracts of natural origin show biological activity at a different levels, and at the same time have a protective effect on the intestinal microbiota. It is important to choose such chemical modifications that increase antimicrobial activity, and at the same time support our immune system and have anti-inflammatory and anti-proliferative properties.
Therefore, articles that compare the biological activity of pathogenic strains and/or intestinal microbiota in the presence of natural compounds/compounds used in medicine in various chemical modifications will be of interest here. Manuscripts examining the effect of plant extracts themselves and pure compounds or their combinations dominant in the plant will also be of interest.
Extracts and their main components obtained as a result of chemical modifications and biotransformations seem to be the future in the fight against infections caused by multidrug-resistant strains.
Dr. Anna Duda-Madej
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- plant extract
- natural compounds
- multidrug-resistant strains
- intestinal microbiota
- chemical modyfication